Dr. John O’Neill

Dr John O’Neill is an Associate Professor in MSK Imaging at McMaster University and St Josephs Healthcare Hamilton. 

He completed his MSK fellowship at McMaster in 2003 and has since developed a strong interest in MSK ultrasound with multiple peer reviewed papers, local/national & International presentations. 

He has held multiple lead imaging roles including MSK fellowship director and chairing the “North American Symposium In MSK Ultrasound”

He completed his first textbook,  MSK Ultrasound, Anatomy & Technique 2008. This included a detailed instruction DVD on approach to MSK ultrasound for upper and lower limb MSK ultrasound. The text has been well received with over 30,000 downloads.
John worked closely with NASA researching and developing manuals for astronaut use of MSK ultrasound in critical injury assessment. This included hands on training and interactive guidance of NASA astronauts using ultrasound in extreme environments. 
John has a strong interest in rheumatology and released his second textbook, Essential Imaging In Rheumatology, in a joint effort with his rheumatology colleagues. This book has also been well received with over 30,000 downloads.
This was followed up with three rheumatology interactive Apps for mobile and desktop downloads: UnRavelling Spondyloarthropathy, UnCovering The Hand Radiograph & Clinical Case Challenge.

John has published multiple peer reviewed papers including a 2019 paper with the first clinical categorization in Axial SpA. 

John has released his third textbook, Imaging Atlas Of Axial Spondyloarthritis and continues to pursue his educational and academic goals. 

Dr. Walter P. Maksymowych

Walter P. Maksymowych, MD F.R.C.P. (C) F.A.C.P., is a Professor and Medical Scientist in the Department of Medicine, Division of Rheumatology at the University of Alberta, Alberta, Canada.

He is the 2012 recipient of the Distinguished Investigator Award from the Canadian Rheumatology Association. He is also Chair of the International OMERACT Soluble Biomarker Working Group, the Scientific Chair of the Alberta Rheumatoid Arthritis and Pharmacovigilance Program and Outcomes Research in Therapeutics (RAPPORT) committee. He is past-Chair of the Scientific Committee of the Canadian Rheumatology Association. He founded CaRE Arthritis Limited, an Alberta company focused on the development of personalized medicine strategies for patients with arthritis, and now serves as Chief Medical Officer.

Dr. Maksymowych graduated from the University of Manchester School of Medicine, United Kingdom, in 1981 and completed his postgraduate training at the University of Alberta and the Children’s Hospital Medical Center, Cincinnati, Ohio. He holds Fellowships in the Royal College of Physicians of Canada and the American College of Physicians. His primary research interests are the imaging and treatment of spondyloarthritis, and the clinical validation of biomarker technologies for rheumatic diseases.

He has published over 350 research articles and is a member of numerous international societies related to arthritis research. His research activities involve a global network of investigators and major partners in the pharmaceutical, imaging, and biomarker industries. He has spearheaded numerous international collaborative networks that have culminated in the development of multiple scoring systems based on imaging and biomarker technologies for use in both diagnostic and therapeutic settings as well as clinical trials research.

Most recently, he co-invented the 14-3-3 biomarker platform which has recently been licensed for diagnostic testing of patients with rheumatoid arthritis.